Escuela de Medicina y Ciencias de la Salud, Tecnologico de Monterrey, Mexico City, Mexico.
Unidad de Investigación de Enfermedades Metabólicas, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Int J Biol Markers. 2024 Jun;39(2):91-106. doi: 10.1177/03936155241239672. Epub 2024 Apr 13.
Biobanks are valuable tools for developing and applying scientific research and international cooperation through the collection of biological materials and their associated data. Systematic research following the Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines was conducted in late 2022 in PubMed and Scopus, and generated 17 articles to be reviewed in depth and critically assessed using the Critical Appraisal Skills Programme Checklist due to the limited available data; 12 relevant health organizations and government websites outside of peer-reviewed journals were also included. Our research identified 44 biobanks in Latin America. In general, there is a lack of regulation and legislation guaranteeing the stored materials' quality and institutional collaboration. We believe a consensus needs to be reached regarding the terminology and definitions used for biobanks. The design for informed consent should also be agreed upon to ensure the privacy of the data shared among institutions. In conclusion, in Latin America, there is a clear need for government support in creating specific procedures for biobanks and providing further support for existing biobanks.
生物银行是通过收集生物材料及其相关数据来开展和应用科学研究及国际合作的宝贵工具。2022 年末，我们按照系统评价和荟萃分析的首选报告项目指南，在 PubMed 和 Scopus 中进行了系统研究，由于可用数据有限，生成了 17 篇文章进行深入审查和批判性评估；此外，我们还查阅了同行评议期刊以外的 12 个相关卫生组织和政府网站。我们的研究在拉丁美洲共发现了 44 个生物银行。总的来说，这些生物银行缺乏监管和立法来保证储存材料的质量和机构间的合作。我们认为，需要就生物银行使用的术语和定义达成共识。还应就知情同意书的设计达成一致，以确保机构间共享数据的隐私性。总之，在拉丁美洲，政府需要支持为生物银行创建具体程序，并为现有的生物银行提供进一步支持。
